4D9-mediated TREM2 activation primarily improved atherosclerosis in LAB Jak2VF by activating a fibrogenic pathway, possibly mediated by macrophage Pdgfb/fibroblast Pdgfra signaling. The gene discussed is PDGFB; the disease is atherosclerosis.